BPMX Insider Trading Activity and SEC Form 4 Filings
BPMX insider trading summary
No open-market insider purchases or sales of BioPharmX Corp (BPMX) have been reported on SEC Form 4 in the past 12 months.
Latest BPMX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 10, 2020 | Timber Pharmaceuticals LLC | 10% Owner | Sell | $550 (55,008 @ $0.01) |
| Feb 10, 2020 | TardiMed Sciences LLC | 10% Owner | Sell | $550 (55,008 @ $0.01) |
| Jun 25, 2019 | Vivo Capital VIII, LLC | 10% Owner | Sell | $334K (327,870 @ $1.02) |
| Jan 23, 2019 | Anja B Krammer | Director | Sell | $13K (115,874 @ $0.11) |
| Oct 22, 2018 | Stephen Morlock | Director | Sell | $45K (251,071 @ $0.18) |
| Oct 22, 2018 | Stephen Morlock | Director | Sell | $40K (220,766 @ $0.18) |
| Oct 19, 2018 | Stephen Morlock | Director | Sell | $39K (214,091 @ $0.18) |
| Oct 18, 2018 | Stephen Morlock | Director | Sell | $83K (439,099 @ $0.19) |
| Oct 12, 2018 | Anja B Krammer | Director | Sell | $57K (297,500 @ $0.19) |
| Oct 11, 2018 | Anja B Krammer | Director | Sell | $19K (100,000 @ $0.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.